Vamifeport
2-[2-[2-(1H-benzimidazol-2-yl)ethylamino]ethyl]-N-[(3-fluoro-2-pyridinyl)methyl]-1,3-oxazole-4-carboxamide
Molecular Identity
Vamifeport
2-[2-[2-(1H-benzimidazol-2-yl)ethylamino]ethyl]-N-[(3-fluoro-2-pyridinyl)methyl]-1,3-oxazole-4-carboxamide
PubChem CID: 129052159
2D Structure
Properties
C21H21FN6O2
Molecular Formula
408.40
Molecular Weight
g/mol
408.1710
Exact Mass
Da
1.9
XLogP
Drug-like (Lipinski: < 5)
109
TPSA
Good oral absorption (< 140 A²)
3
H-Bond Donors
7
H-Bond Acceptors
556
Complexity
SMILES
Canonical SMILES
SMILES: C1=CC=C2C(=C1)NC(=N2)CCNCCC3=NC(=CO3)C(=O)NCC4=C(C=CC=N4)FIsomeric SMILES
SMILES: C1=CC=C2C(=C1)NC(=N2)CCNCCC3=NC(=CO3)C(=O)NCC4=C(C=CC=N4)FSynonyms(20)
VIT-2763Vamifeport2095668-10-1FUF66UD0KRVIT-2763-PM12-[2-[2-(1H-benzimidazol-2-yl)ethylamino]ethyl]-N-[(3-fluoropyridin-2-yl)methyl]-1,3-oxazole-4-carboxamide2-(2-((2-(1H-Benzimidazol-2-yl)ethyl)amino)ethyl)-N-((3-fluoropyridin-2-yl)methyl)-1,3-oxazole-4-carboxamide4-Oxazolecarboxamide, 2-(2-((2-(1H-benzimidazol-2-yl)ethyl)amino)ethyl)-N-((3-fluoro-2-pyridinyl)methyl)-2-(2-(2-(1H-benzimidazol-2-yl)ethylamino)ethyl)-N-((3-fluoropyridin-2-yl)methyl)-1,3-oxazole-4-carboxamideRefChem:193643Vamifeport [INN]Vamifeport [USAN]Vamifeport [USAN:INN]UNII-FUF66UD0KRSCHEMBL18764615
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Vamifeport
Loading drug network...